|
Young Smoker's Reactions to Genetic Risk for Lung Cancer
|
5R01CA121922-03
|
$251,910
|
$251,910
|
LIPKUS, ISAAC
|
DUKE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-31
|
$1,889,710
|
$18,897
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Wnt Antagonist Gene Hypermethylation in Circulating DNA: Cancer Biomarker
|
ZIA BC 011050
|
$55,899
|
$55,899
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
Vitamin D and Colorectal Cancer
|
5R01CA122299-02
|
$345,845
|
$172,923
|
BENYA, RICHARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Validation of genomic targets in melanoma
|
5R01CA114337-05
|
$294,871
|
$294,871
|
KASHANI-SABET, MOHAMMED
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Validation and extension of the PREMM Model for mismatch repair gene mutations
|
5R01CA132829-02
|
$396,689
|
$99,172
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INSTITUTE
|
|
Validating Molecular Signature Risk Models of NSCLC
|
5R01CA116648-04
|
$455,257
|
$227,629
|
HARPOLE, DAVID
|
DUKE UNIVERSITY
|
|
Utah Breast Cancer Family Registry
|
5U01CA069446-15
|
$194,477
|
$194,477
|
BUYS, SAUNDRA
|
UNIVERSITY OF UTAH
|
|
UT M.D. Anderson Cancer Center SPORE in Melanoma
|
3P50CA093459-05S1
|
$1,079,303
|
$215,861
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-21
|
$2,091,787
|
$62,754
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Use of Quantitative RT-PCR for Staging Esophageal Cancer
|
5R01CA090665-09
|
$271,168
|
$271,168
|
LUKETICH, JAMES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Use of CCI-779 in multiple myeloma
|
5R21CA121464-02
|
$319,950
|
$79,988
|
LICHTENSTEIN, ALAN
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-34S1
|
$74,165
|
$14,833
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-34S2
|
$100,000
|
$20,000
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-34
|
$6,658,653
|
$1,331,731
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S2
|
$1,678,886
|
$302,199
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S3
|
$80,987
|
$14,578
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S4
|
$99,840
|
$17,971
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
3P50CA100632-07S1
|
$52,857
|
$6,343
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-07
|
$2,300,000
|
$276,000
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-05S2
|
$60,764
|
$2,431
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-05
|
$1,371,380
|
$54,855
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-22S1
|
$61,058
|
$1,832
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-22
|
$5,994,681
|
$179,840
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Translational Medicine and Cancer Therapy with Vasculature-Targeted Agents
|
5K23CA124802-03
|
$129,843
|
$129,843
|
Maitland, Michael
|
UNIVERSITY OF CHICAGO
|
|
Translational Applications of mda-7/IL-24 in Cancer
|
5P01CA104177-05
|
$1,353,467
|
$1,353,467
|
FISHER, PAUL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Transformation by the NEU Oncogene Product and EGF
|
5R01CA045708-21
|
$357,470
|
$117,965
|
STERN, DAVID
|
YALE UNIVERSITY
|
|
Towards Understanding Prostate Cancer Heterogeneity
|
5R01CA125612-03
|
$365,372
|
$365,372
|
RUBIN, MARK
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
Toward a molecular classification of human gliomas
|
2R01CA057683-16
|
$310,275
|
$310,275
|
LOUIS, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Tobacco Smoke Sensitive Genes and Genetic Susceptibility to Small-Cell Lung Cance
|
5R03CA133885-02
|
$77,000
|
$77,000
|
GORLOV, IVAN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Self Regulation Model in BRCA 1/2 Genetic Counseling
|
5R03CA128459-02
|
$75,000
|
$75,000
|
Kelly, Kimberly
|
OHIO STATE UNIVERSITY
|
|
The Role of Behavioral Science in Personalized Genetic Medicine
|
5K07CA131172-02
|
$136,890
|
$136,890
|
GRAVES, KRISTI
|
GEORGETOWN UNIVERSITY
|
|
The Role of Aberrant Splicing of EVl1 in Ovarian Cancer Pathophysiology
|
5R01CA123219-02
|
$314,578
|
$78,645
|
MILLS, GORDON
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Pathogenesis of Dyskeratosis Congenita
|
5R01CA106995-05
|
$286,517
|
$286,517
|
MASON, PHILIP
|
WASHINGTON UNIVERSITY
|
|
The NIH Pediatric and wildtype GIST Clinic
|
ZIA BC 011196
|
$49,051
|
$9,810
|
Kim, Su Young
|
CCR (NCI)
|
|
The Molecular Basis for Bortezomib Activity
|
5R01CA129009-03
|
$304,166
|
$76,042
|
STEWART, A
|
MAYO CLINIC COLL OF MED, MAYO CLINIC AZ
|
|
The IGF Signaling Pathway and Breast Cancer Risk
|
5R01CA116494-03
|
$502,157
|
$502,157
|
Neuhausen, Susan
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
5R01CA124709-02
|
$666,482
|
$666,482
|
MARIS, JOHN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
The Colon Cancer Family Registry: USC Consortium
|
3U24CA074799-10S1
|
$154,040
|
$77,020
|
HAILE, ROBERT
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
The Colon Cancer Family Registry: USC Consortium
|
5U24CA074799-11
|
$1,816,228
|
$908,114
|
HAILE, ROBERT
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
The Colon Cancer Family Registry: Hawaii
|
3U24CA074806-10S1
|
$9,324
|
$4,662
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
The Colon Cancer Family Registry: Hawaii
|
5U24CA074806-11
|
$447,582
|
$223,791
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
The Colon Cancer Family Registry: Australasia
|
3U24CA097735-06S1
|
$41,675
|
$20,838
|
HOPPER, JOHN
|
UNIVERSITY OF MELBOURNE
|
|
The Colon Cancer Family Registry: Australasia
|
5U24CA097735-07
|
$1,586,795
|
$793,398
|
HOPPER, JOHN
|
UNIVERSITY OF MELBOURNE
|
|
Telomere dysfunction, chromosome 9 instability and bladder cancer risk
|
1R01CA132996-01A2
|
$603,945
|
$452,959
|
ZHENG, YUN-LING
|
GEORGETOWN UNIVERSITY
|
|
Taxane Resistance in Breast and Ovarian Cancer Cells
|
5R01CA114037-03
|
$297,730
|
$148,865
|
SIKIC, BRANIMIR
|
STANFORD UNIVERSITY
|
|
Targets to Therapeutics in Pancreatic Cancer
|
5P01CA109552-05
|
$3,046,343
|
$2,284,757
|
VON HOFF, DANIEL
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
|
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) EXPANSION PROGRAM
|
N01PC544002-013
|
$1,683,982
|
$420,996
|
CHEN, VIVIEN
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER) EXPANSION PROGRAM
|
N01PC544005-012
|
$1,254,095
|
$313,524
|
TAN, CHRISTIANA
|
NEW JERSEY DEPARTMENT OF HEALTH AND SENI
|
|
SURVEILLANCE , EPIDEMIOLOGY AND END RESULTS (SEER) PROGRAM
|
N01PC544004-013
|
$2,295,340
|
$573,835
|
CRESS, ROSEMARY
|
PUBLIC HEALTH INSTITUTE:1110113
|
Total relevant funding to Genetic Testing for this search: $133,833,813
|